Article Information
History
- November 20, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- B. Van Puyvelde1,
- K. Van Uytfanghe2,
- O. Tytgat1,9,
- L. Van Oudenhove3,
- R. Gabriels4,5,
- R. Bouwmeester4,5,
- S. Daled1,
- T. Van Den Bossche4,5,
- P. Ramasamy4,5,16,
- S. Verhelst1,
- L. De Clerck1,
- L. Corveleyn1,
- N. Debunne21,
- E. Wynendaele21,
- B. De Spiegeleer21,
- P. Judak11,
- K. Roels11,
- L. De Wilde11,
- P. Van Eenoo11,
- T. Reyns12,
- M. Cherlet17,
- E. Dumont18,
- G. Debyser18,
- R. t’Kindt18,
- K. Sandra18,
- S. Gupta4,5,
- Nicolas Drouin19,
- Amy Harms19,
- Thomas Hankemeier19,
- DJL Jones13,
- P. Gupta14,
- D. Lane14,
- C.S. Lane10,
- S. El Ouadi10,
- JB. Vincendet10,
- N. Morrice10,
- S. Oehrle20,
- N. Tanna20,
- S. Silvester15,
- S. Hannam15,
- F. Sigloch6,
- A. Bhangu-Uhlmann6,
- J. Claereboudt3,
- L. Anderson22,
- M. Razavi22,
- S. Degroeve4,5,
- L. Cuypers7,
- C. Stove2,
- K. Lagrou7,
- G. Martens8,
- D. Deforce1,
- L. Martens4,5,
- J.P.C. Vissers20 and
- M. Dhaenens1,*
- 1ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium
- 2Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- 3Waters Corporation, Antwerp, Belgium
- 4VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium
- 5Department of Biomolecular Medicine, Ghent University, Ghent Belgium
- 6Polyquant GmbH, Bad Abbach, Germany
- 7Clinical Department of Laboratory Medicine, UZ Leuven, KU Leuven, Leuven, Belgium
- 8AZ Delta Medical Laboratories, AZ Delta General Hospital, Roeselare, Belgium
- 9Department of Life Science Technologies, Imec, Leuven, Belgium
- 10Sciex, Macclesfield, UK
- 11Doping Control Laboratory, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium
- 12Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium
- 13Leicester Cancer Research Centre, RKCSB, University of Leicester, UK and John and Lucille van Geest biomarker facility, Cardiovascular Research Centre, Glenfield Hospital, Leicester, UK
- 14The Department of Chemical Pathology and Metabolic Diseases, Level 4, Sandringham Building, Leicester Royal Infirmary, Leicester, United Kingdom
- 15Alderley Analytical, Macclesfield, UK
- 16Interuniversity Institute of Bioinformatics in Brussels, ULB/VUB, Brussels, Belgium
- 17Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Veterinary Medicine, Ghent University, Belgium
- 18Research Institute for Chromatography (RIC), Kortrijk, Belgium
- 19Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, 2311 G Leiden, The Netherlands
- 20Waters Corporation, Milford, MA / Waters Corporation, Wilmslow, UK
- 21Drug Quality and Registration Group, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
- 22SISCAPA Assay Technologies, Inc., Washington DC USA and Victoria BC Canada
- ↵*Corresponding author: maarten.dhaenens{at}ugent.be